SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bogdanich W. Lax laboratories: the Pap test misses much cervical cancer through labs' errors. Wall Street J. 1987; 210: 1,20.
  • 2
    Clinical Laboratory Improvement Amendments of 1988. Final Rule. United States Department of Health and Human Services. Washington, DC: US Government Printing Office. Fed Reg. 1992;57: 70017288.
  • 3
    Cioc AM,Julius CJ,Proca DM, et al. Cervical biopsy/cytology correlation data can be collected prospectively and shared clinically. Diagn Cytopathol. 2002; 26: 4952.
  • 4
    Byrne P,Jordan J,Williams D,Woodman C. Importance of negative result of cervical biopsy directed by colposcopy. BMJ. 1988; 296: 172.
  • 5
    SolomonD, NayarR (eds.). The Bethesda System for Reporting Cervical Cytology.2nd ed. New York: Springer; 2004.
  • 6
    Wright TCJr,Cox JT,Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287: 21202127.
  • 7
    Lindeque BG. Management of cervical premalignant lesions. Best Pract Res Clin Obstet Gynaecol. 2005; 19: 545561.
  • 8
    Padilla-Paz LA,Carlson J,Twiggs LB, et al. Evidence supporting the current management guidelines for high-grade squamous intraepithelial lesion cytology. J Low Genit Tract Dis. 2004; 8: 139146.
  • 9
    Dunn TS,Burke M,Shwayder J. A “see and treat” management for high-grade squamous intraepithelial lesion Pap smears. J Low Genit Tract Dis. 2003; 7: 104106.
  • 10
    Holschneider CH,Ghosh K,Montz FJ. See and treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet Gynecol. 1999; 94: 377385.
  • 11
    Megevand E,Van Wyk W,Knight B,Bloch B, Can cervical cancer be prevented by a see, screen, and treat program? A pilot study. Am J Obstet Gynecol. 1996; 174: 923928.
  • 12
    Bigrigg A,Haffenden DK,Sheehan AL, et al. Efficacy and safety of large-loop excision of the transformation zone. Lancet. 1994; 343: 3234.
  • 13
    Brown FM,Faquin WC,Sun D,Crum CP,Cibas ES. LSIL biopsies after HSIL smears: correlation with high-risk HPV and greater risk of HSIL on follow-up. Am J Clin Pathol. 1999; 112: 765768.
  • 14
    Cramer H,Schlenk E. An analysis of discrepancies between the cervical cytologic diagnosis and subsequent histopathologic diagnosis in 1260 cases [Abstract]. Acta Cytol. 1994; 39: 812.
  • 15
    Ibrahim SN,Krigman HR,Coogan AC, et al. Prospective correlation of cervicovaginal cytologic and histologic specimens. Am J Clin Pathol. 1996; 106: 319324.
  • 16
    Jones BA,Novis DA. Cervical biopsy – cytology correlation. A College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996; 120: 523531.
  • 17
    Joste NE,Crum CP,Cibas ES. Cytologic/histologic correlation for quality control in cervicovaginal cytology: experience with 1,582 paired cases. Am J Clin Pathol. 1995; 103: 3234.
  • 18
    Rohr LR. Quality assurance in gynecologic cytology: what is practical? Am J Clin Pathol. 1990; 94: 754758.
  • 19
    Raab SS,Stone CH,Wojcik EM, et al. Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancy. Am J Clin Pathol. 2006; 126: 836842.
  • 20
    Andersen ES,Nielsen K,Pedersen B. The reliability of preconization diagnostic evaluation in patients with cervical intraepithelial neoplasia and microinvasive carcinoma. Gynecol Oncol. 1995; 59: 143147.
  • 21
    Howell LP,Zhou H,Wu W,Davis R. Significance of subclassifying high-grade squamous intraepithelial lesions into moderate dysplasia/CIN II versus severe dysplasia/CIN III/CIS in the Bethesda system terminology. Diagn Cytopathol. 2004; 30: 362366.
  • 22
    Solomon D,Davey D,Kurman R, et al. The 2001 Bethesda system: terminology for reporting result of cervical cytology. JAMA. 2002; 287: 21142119.
  • 23
    Dray M,Russell P,Dalrymple C, et al. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I. Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology. 2005; 37: 112124.
  • 24
    Agoff SN,Lin P,Morihara J, et al. p16INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 2003; 16: 665673.